China
· Delayed Price · Currency is CNY Shanghai Shyndec Pharmaceutical Company Description
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China.
The company offers 6-APA, 7-ADCA, 7-ACA, D-7ACA, penicillin industrial potassium; pharmaceutical intermediates, anti-infective pharmaceutical intermediates salt, ceftriaxone sodium crude salt; and amoxicillin, clavulanic acid series, azithromycin, and ceftriaxone sodium.
It also provides anti-infective pharmaceutical raw materials; urogenital system pharmaceutical raw materials, systemic anti-infective drugs; cardiovascular system medications; urogenital system medications and hormones; drugs for the nervous system; diclofenac sodium sustained-release tablets for musculoskeletal system; digestive tract and metabolism medications; anti-tumor and immunomodulatory agent; blood and hematopoietic system medication; respiratory system medications; animal vaccines; and general health products.
Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shanghai, China.
| Country | China |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 11,608 |
| CEO | Yong Liu |
Contact Details
Address: No. 378, Jianlu Road Shanghai, 200137 China | |
| Phone | 86 21 6251 0990 |
| Website | shyndec.com |
Stock Details
| Ticker Symbol | 600420 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001JG2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yong Liu | Vice Chairman of the Board and President |
| Xian Lin Li | Vice President and General Counsel |
| Dongsong Wei | Vice President and Secretary of the Board of Directors |
| Feng Ni | Vice President |
| Jing Zu | Chief Financial Officer |